Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.
Svenja KramerArash HaghikiaClaudia BangKristian ScherfAngelika PfanneAlexander DuschaJohannes KaislerBarbara GiseviusRalf GoldThomas ThumAiden HaghikiaPublished in: Neurology(R) neuroimmunology & neuroinflammation (2019)
This study provides Class III evidence that CSF-derived miR-181c and miR-633 distinguish patients with MS from patients with OND.